Annual Revenue
$1.89 B
+$398.40 M+26.76%
31 December 2023
Summary:
Neurocrine Biosciences annual revenue is currently $1.89 billion, with the most recent change of +$398.40 million (+26.76%) on 31 December 2023. During the last 3 years, it has risen by +$841.20 million (+80.43%). NBIX annual revenue is now at all-time high.NBIX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$622.10 M
+$31.90 M+5.40%
30 September 2024
Summary:
Neurocrine Biosciences quarterly revenue is currently $622.10 million, with the most recent change of +$31.90 million (+5.40%) on 30 September 2024. Over the past year, it has increased by +$123.30 million (+24.72%). NBIX quarterly revenue is now at all-time high.NBIX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.24 B
+$123.30 M+5.82%
30 September 2024
Summary:
Neurocrine Biosciences TTM revenue is currently $2.24 billion, with the most recent change of +$123.30 million (+5.82%) on 30 September 2024. Over the past year, it has increased by +$458.90 million (+25.72%). NBIX TTM revenue is now at all-time high.NBIX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.8% | +24.7% | +25.7% |
| 3 y3 years | +80.4% | +110.2% | +109.7% |
| 5 y5 years | +318.2% | +180.1% | +232.0% |
NBIX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +80.4% | at high | +110.2% | at high | +109.7% |
| 5 y | 5 years | at high | +318.2% | at high | +180.1% | at high | +232.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Neurocrine Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $622.10 M(+5.4%) | $2.24 B(+5.8%) |
| June 2024 | - | $590.20 M(+14.5%) | $2.12 B(+6.9%) |
| Mar 2024 | - | $515.30 M(+0.0%) | $1.98 B(+5.0%) |
| Dec 2023 | $1.89 B(+26.8%) | $515.20 M(+3.3%) | $1.89 B(+5.8%) |
| Sept 2023 | - | $498.80 M(+10.2%) | $1.78 B(+6.6%) |
| June 2023 | - | $452.70 M(+7.7%) | $1.67 B(+4.7%) |
| Mar 2023 | - | $420.40 M(+2.0%) | $1.60 B(+7.4%) |
| Dec 2022 | $1.49 B(+31.3%) | $412.00 M(+6.2%) | $1.49 B(+7.2%) |
| Sept 2022 | - | $387.90 M(+2.6%) | $1.39 B(+7.1%) |
| June 2022 | - | $378.20 M(+21.8%) | $1.30 B(+7.4%) |
| Mar 2022 | - | $310.60 M(-0.4%) | $1.21 B(+6.5%) |
| Dec 2021 | $1.13 B(+8.4%) | $312.00 M(+5.4%) | $1.13 B(+6.0%) |
| Sept 2021 | - | $296.00 M(+2.5%) | $1.07 B(+3.6%) |
| June 2021 | - | $288.90 M(+22.1%) | $1.03 B(-1.3%) |
| Mar 2021 | - | $236.60 M(-4.6%) | $1.05 B(-0.0%) |
| Dec 2020 | $1.05 B(+32.7%) | $247.90 M(-4.1%) | $1.05 B(+0.4%) |
| Sept 2020 | - | $258.50 M(-14.5%) | $1.04 B(+3.6%) |
| June 2020 | - | $302.40 M(+27.5%) | $1.01 B(+13.4%) |
| Mar 2020 | - | $237.10 M(-2.9%) | $886.80 M(+12.5%) |
| Dec 2019 | $788.10 M(+74.7%) | $244.10 M(+9.9%) | $788.10 M(+16.7%) |
| Sept 2019 | - | $222.10 M(+21.0%) | $675.45 M(+11.6%) |
| June 2019 | - | $183.50 M(+32.6%) | $605.11 M(+16.7%) |
| Mar 2019 | - | $138.40 M(+5.3%) | $518.51 M(+14.9%) |
| Dec 2018 | $451.20 M(+179.2%) | $131.45 M(-13.4%) | $451.20 M(+8.9%) |
| Sept 2018 | - | $151.76 M(+56.6%) | $414.26 M(+28.1%) |
| June 2018 | - | $96.91 M(+36.3%) | $323.28 M(+38.9%) |
| Mar 2018 | - | $71.09 M(-24.8%) | $232.71 M(+44.0%) |
| Dec 2017 | $161.63 M(+977.5%) | $94.52 M(+55.5%) | $161.63 M(+140.8%) |
| Sept 2017 | - | $60.77 M(+859.3%) | $67.11 M(+959.3%) |
| June 2017 | - | $6.33 M(-57.8%) | $6.33 M(-57.8%) |
| Dec 2016 | $15.00 M(-24.1%) | - | - |
| Mar 2016 | - | $15.00 M(-24.1%) | $15.00 M(-24.1%) |
| Dec 2015 | $19.77 M(+577.3%) | - | - |
| Mar 2015 | - | $19.77 M(+2608.1%) | $19.77 M(+577.3%) |
| Dec 2013 | $2.92 M(-94.5%) | $730.00 K(+0.1%) | $2.92 M(-87.9%) |
| Sept 2013 | - | $729.00 K(-0.1%) | $24.14 M(-26.3%) |
| June 2013 | - | $730.00 K(0.0%) | $32.76 M(-23.1%) |
| Mar 2013 | - | $730.00 K(-96.7%) | $42.60 M(-19.8%) |
| Dec 2012 | $53.14 M(-31.4%) | $21.95 M(+134.6%) | $53.14 M(+25.6%) |
| Sept 2012 | - | $9.36 M(-11.5%) | $42.30 M(-43.3%) |
| June 2012 | - | $10.57 M(-6.2%) | $74.58 M(-2.1%) |
| Mar 2012 | - | $11.27 M(+1.4%) | $76.17 M(-1.6%) |
| Dec 2011 | $77.41 M(+131.1%) | $11.11 M(-73.3%) | $77.41 M(-3.2%) |
| Sept 2011 | - | $41.63 M(+242.5%) | $79.96 M(+51.5%) |
| June 2011 | - | $12.16 M(-2.8%) | $52.77 M(+16.6%) |
| Mar 2011 | - | $12.51 M(-8.4%) | $45.26 M(+35.1%) |
| Dec 2010 | $33.50 M(+1034.5%) | $13.66 M(-5.5%) | $33.50 M(+62.8%) |
| Sept 2010 | - | $14.45 M(+211.2%) | $20.58 M(+199.7%) |
| June 2010 | - | $4.64 M(+516.6%) | $6.87 M(+132.1%) |
| Mar 2010 | - | $753.00 K(+1.8%) | $2.96 M(+0.2%) |
| Dec 2009 | $2.95 M | $740.00 K(+1.0%) | $2.95 M(+0.4%) |
| Sept 2009 | - | $733.00 K(0.0%) | $2.94 M(-0.9%) |
| June 2009 | - | $733.00 K(-1.9%) | $2.97 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $747.00 K(+2.5%) | $2.97 M(-25.3%) |
| Dec 2008 | $3.98 M(+224.8%) | $729.00 K(-4.2%) | $3.98 M(+5.2%) |
| Sept 2008 | - | $761.00 K(+3.7%) | $3.78 M(+6.2%) |
| June 2008 | - | $734.00 K(-58.1%) | $3.56 M(+23.9%) |
| Mar 2008 | - | $1.75 M(+229.1%) | $2.87 M(+134.6%) |
| Dec 2007 | $1.22 M(-96.9%) | $532.00 K(-1.5%) | $1.22 M(-87.9%) |
| Sept 2007 | - | $540.00 K(+1025.0%) | $10.13 M(-5.0%) |
| June 2007 | - | $48.00 K(-53.8%) | $10.67 M(-46.3%) |
| Mar 2007 | - | $104.00 K(-98.9%) | $19.86 M(-49.4%) |
| Dec 2006 | $39.23 M(-68.3%) | $9.44 M(+779.0%) | $39.23 M(-10.6%) |
| Sept 2006 | - | $1.07 M(-88.4%) | $43.91 M(-59.2%) |
| June 2006 | - | $9.24 M(-52.5%) | $107.58 M(-18.2%) |
| Mar 2006 | - | $19.48 M(+38.0%) | $131.50 M(+6.1%) |
| Dec 2005 | $123.89 M(+45.5%) | $14.11 M(-78.2%) | $123.89 M(-3.4%) |
| Sept 2005 | - | $64.75 M(+95.2%) | $128.26 M(+30.6%) |
| June 2005 | - | $33.17 M(+179.6%) | $98.22 M(+22.6%) |
| Mar 2005 | - | $11.86 M(-35.8%) | $80.10 M(-6.0%) |
| Dec 2004 | $85.18 M(-38.8%) | $18.48 M(-46.7%) | $85.18 M(-9.2%) |
| Sept 2004 | - | $34.70 M(+130.6%) | $93.83 M(+6.2%) |
| June 2004 | - | $15.05 M(-11.2%) | $88.38 M(-25.3%) |
| Mar 2004 | - | $16.94 M(-37.6%) | $118.30 M(-14.9%) |
| Dec 2003 | $139.08 M(+670.7%) | $27.14 M(-7.3%) | $139.08 M(+20.1%) |
| Sept 2003 | - | $29.26 M(-34.9%) | $115.82 M(+26.5%) |
| June 2003 | - | $44.97 M(+19.2%) | $91.55 M(+80.2%) |
| Mar 2003 | - | $37.72 M(+872.6%) | $50.80 M(+181.5%) |
| Dec 2002 | $18.05 M(-56.2%) | $3.88 M(-22.2%) | $18.05 M(-33.2%) |
| Sept 2002 | - | $4.98 M(+17.9%) | $27.00 M(-38.1%) |
| June 2002 | - | $4.23 M(-14.7%) | $43.61 M(+2.1%) |
| Mar 2002 | - | $4.96 M(-61.4%) | $42.71 M(+3.6%) |
| Dec 2001 | $41.24 M(+182.7%) | $12.83 M(-40.6%) | $41.24 M(+29.1%) |
| Sept 2001 | - | $21.59 M(+548.8%) | $31.95 M(+103.7%) |
| June 2001 | - | $3.33 M(-4.6%) | $15.68 M(+2.5%) |
| Mar 2001 | - | $3.49 M(-1.6%) | $15.30 M(+4.9%) |
| Dec 2000 | $14.59 M(-13.2%) | $3.54 M(-33.4%) | $14.59 M(-4.3%) |
| Sept 2000 | - | $5.32 M(+80.9%) | $15.24 M(+0.8%) |
| June 2000 | - | $2.94 M(+5.9%) | $15.12 M(-5.4%) |
| Mar 2000 | - | $2.78 M(-33.9%) | $15.99 M(-4.9%) |
| Dec 1999 | $16.80 M(+5.0%) | $4.20 M(-19.2%) | $16.81 M(-1.8%) |
| Sept 1999 | - | $5.20 M(+36.5%) | $17.11 M(+0.6%) |
| June 1999 | - | $3.81 M(+5.8%) | $17.01 M(+9.7%) |
| Mar 1999 | - | $3.60 M(-20.0%) | $15.50 M(-3.1%) |
| Dec 1998 | $16.00 M(-38.7%) | $4.50 M(-11.8%) | $16.00 M(-9.6%) |
| Sept 1998 | - | $5.10 M(+121.7%) | $17.70 M(-5.9%) |
| June 1998 | - | $2.30 M(-43.9%) | $18.80 M(-11.7%) |
| Mar 1998 | - | $4.10 M(-33.9%) | $21.30 M(-18.4%) |
| Dec 1997 | $26.10 M(+35.9%) | $6.20 M(0.0%) | $26.10 M(-10.6%) |
| Sept 1997 | - | $6.20 M(+29.2%) | $29.20 M(+15.9%) |
| June 1997 | - | $4.80 M(-46.1%) | $25.20 M(-2.7%) |
| Mar 1997 | - | $8.90 M(-4.3%) | $25.90 M(+34.9%) |
| Dec 1996 | $19.20 M | $9.30 M(+322.7%) | $19.20 M(+93.9%) |
| Sept 1996 | - | $2.20 M(-60.0%) | $9.90 M(+28.6%) |
| June 1996 | - | $5.50 M(+150.0%) | $7.70 M(+250.0%) |
| Mar 1996 | - | $2.20 M | $2.20 M |
FAQ
- What is Neurocrine Biosciences annual revenue?
- What is the all time high annual revenue for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual revenue year-on-year change?
- What is Neurocrine Biosciences quarterly revenue?
- What is the all time high quarterly revenue for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly revenue year-on-year change?
- What is Neurocrine Biosciences TTM revenue?
- What is the all time high TTM revenue for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM revenue year-on-year change?
What is Neurocrine Biosciences annual revenue?
The current annual revenue of NBIX is $1.89 B
What is the all time high annual revenue for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual revenue is $1.89 B
What is Neurocrine Biosciences annual revenue year-on-year change?
Over the past year, NBIX annual revenue has changed by +$398.40 M (+26.76%)
What is Neurocrine Biosciences quarterly revenue?
The current quarterly revenue of NBIX is $622.10 M
What is the all time high quarterly revenue for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly revenue is $622.10 M
What is Neurocrine Biosciences quarterly revenue year-on-year change?
Over the past year, NBIX quarterly revenue has changed by +$123.30 M (+24.72%)
What is Neurocrine Biosciences TTM revenue?
The current TTM revenue of NBIX is $2.24 B
What is the all time high TTM revenue for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM revenue is $2.24 B
What is Neurocrine Biosciences TTM revenue year-on-year change?
Over the past year, NBIX TTM revenue has changed by +$458.90 M (+25.72%)